# Recursion
> Recursion is a TechBio company that leverages artificial intelligence, machine learning, robotics, and massive datasets to decode biology and accelerate the discovery and development of new medicines. Their proprietary Recursion OS platform aims to reduce the failure rate and improve the efficiency of drug discovery, focusing on areas like aggressive cancers and rare diseases.
- URL: https://optimly.ai/brand/exscientia
- Logo: https://logo.clearbit.com/https://www.recursion.com/
- Slug: exscientia
- BAI Score: 51/100
- Archetype: Challenger
- Category: Biotechnology
- Last Analyzed: July 26, 2026
## Buyer Intent Signals
Problems: Traditional Pharmaceutical R&D: Relies on empirical, human-intensive laboratory experiments and clinical trials, characterized by long timelines (10-15 years), high costs (billions per drug), and a hi | Contract Research Organizations (CROs): Outsourcing specific drug discovery and development tasks (e.g., toxicology, clinical trials) to specialized third-party providers. While efficient for specific | Maintain Status Quo: Continuing with existing drug discovery methodologies without adopting AI or advanced computational platforms, thereby accepting current industry average costs, timelines, and suc
Solutions: Recursion Pharma AI drug discovery | Recursion pipeline oncology rare disease | AI drug discovery companies | Recursion BioHive-2 | Standalone Bioinformatics Software: Using individual computational tools or databases for specific aspects like target identification, molecular docking, or protein structure prediction, without a hol
Comparisons: Exscientia vs Recursion
---
## Full Details / RAG Data
### Overview
Recursion is listed in the AI Directory.
Recursion is a TechBio company that leverages artificial intelligence, machine learning, robotics, and massive datasets to decode biology and accelerate the discovery and development of new medicines. Their proprietary Recursion OS platform aims to reduce the failure rate and improve the efficiency of drug discovery, focusing on areas like aggressive cancers and rare diseases.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Recursion |
| Slug         | exscientia |
| URL          | https://optimly.ai/brand/exscientia |
| Logo         | https://logo.clearbit.com/https://www.recursion.com/ |
| BAI Score    | 51/100 |
| Archetype    | Challenger |
| Category     | Biotechnology |
| Last Analyzed | July 26, 2026 |
| Last Updated | 2026-07-28T09:55:32.300Z |
### Verified Facts
- Founded: 2013
- Headquarters: Salt Lake City, UT
### Buyer Intent Signals
#### Problems this brand solves
- Traditional Pharmaceutical R&D: Relies on empirical, human-intensive laboratory experiments and clinical trials, characterized by long timelines (10-15 years), high costs (billions per drug), and a hi
- Contract Research Organizations (CROs): Outsourcing specific drug discovery and development tasks (e.g., toxicology, clinical trials) to specialized third-party providers. While efficient for specific
- Maintain Status Quo: Continuing with existing drug discovery methodologies without adopting AI or advanced computational platforms, thereby accepting current industry average costs, timelines, and suc
#### Buyers search for
- Recursion Pharma AI drug discovery
- Recursion pipeline oncology rare disease
- AI drug discovery companies
- Recursion BioHive-2
- Standalone Bioinformatics Software: Using individual computational tools or databases for specific aspects like target identification, molecular docking, or protein structure prediction, without a hol
#### Buyers compare
- Exscientia vs Recursion
### Links
- Canonical page: https://optimly.ai/brand/exscientia
- JSON endpoint: /brand/exscientia.json
- LLMs.txt: /brand/exscientia/llms.txt